NUK - logo
E-viri
Celotno besedilo
Recenzirano
  • Randomized control trial on...
    Ikechebelu, Joseph I.; Eleje, George U.; Joe-Ikechebelu, Ngozi N.; Okafor, Chidimma Donatus; Okpala, Boniface Chukwuneme; Ugwu, Emmanuel O.; Nwachukwu, Cyril Emeka; Okoro, Chukwuemeka C.; Okam, Princeston C.

    Archives of gynecology and obstetrics, 09/2021, Letnik: 304, Številka: 3
    Journal Article

    Purpose To determine the benefits and safety of direct trocar insertion versus Veress needle technique in obese women undertaking diagnostic laparoscopy procedures. Methods Randomized-controlled trial on 135 obese women undergoing diagnostic laparoscopy and dye test for infertility was conducted. Women were randomly assigned to either direct trocar access ( n  = 68) or Veress needle access ( n  = 67) before achieving pneumoperitoneum. The same surgeon executed the laparoscopic techniques with a single-puncture technique. The primary outcome measures included total length of the procedure and incidence of any complications, while the mean laparoscopic entry time, volume of CO 2 required, and total of tries needed to attain successful entry were secondary outcomes. Intention-to-treat principle was applied to analysis. Results Women in both groups had similar socio-demographic and clinical characteristics and none were lost to follow-up. The overall length of the procedure was significantly lesser in the direct trocar group compared to the Veress needle group (9.9 ± 6.0 vs 16.7 ± 4.7 min; p  < 0.001). No significant differences occurred in other outcomes including mean entry time, volume of CO 2 used, number of attempts for successful entry, and major/minor complications ( p  > 0.05). Conclusions Direct trocar technique may be an effective alternative to Veress needle for pneumoperitoneum in obese women for diagnostic laparoscopy. It has a comparable rapid laparoscopic entry time but a significantly lower duration of the procedure and shorter exposure to anesthesia. Both methods are equally effective as there was no significant difference in the complications recorded. A greater sample trial may be essential for more corroborative substantiation. Clinical trial registration: PACTR201510000999192.